87458 Federal Register / Vol. 88, No. 241 / Monday, December 18, 2023 / Notices 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

close of business, eight calendar days 

after the date of publication of this 

notice in the Federal Register. There 

will be further opportunities for 

comment on the public interest after the 

issuance of any final initial 

determination in this investigation. Any 

written submissions on other issues 

must also be filed by no later than the 

close of business, eight calendar days 

after publication of this notice in the 

Federal Register. Complainant may file 

replies to any written submissions no 

later than three calendar days after the 

date on which any initial submissions 

were due, notwithstanding § 201.14(a) 

of the Commission’s Rules of Practice 

and Procedure. No other submissions 

will be accepted, unless requested by 

the Commission. Any submissions and 

replies filed in response to this Notice 

are limited to five (5) pages in length, 

inclusive of attachments. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. Submissions should refer 

to the docket number (‘‘Docket No. 

3712’’) in a prominent place on the 

cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, Electronic Filing 

Procedures 1). Please note the 

Secretary’s Office will accept only 

electronic filings during this time. 

Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov.) No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. Persons with questions 

regarding filing should contact the 

Secretary atEDIS3Help@usitc.gov. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: December 13, 2023. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2023–27767 Filed 12–15–23; 8:45 am] 

BILLING CODE 7020–02–P 

JUDICIAL CONFERENCE OF THE 

UNITED STATES 

Advisory Committee on Bankruptcy 

Rules; Hearing of the Judicial 

Conference 

AGENCY: Judicial Conference of the 

United States. 

ACTION: Advisory Committee on 

Bankruptcy Rules; Notice of 

cancellation of open hearing. 

SUMMARY: The following public hearing 

on proposed amendments to the Federal 

Rules of Bankruptcy Procedure has been 

canceled: Bankruptcy Rules Hearing on 

January 12, 2024. The announcement for 

this hearing was previously published 

in the Federal Register on August 9, 

2023. 

DATES: January 12, 2024. 

FOR FURTHER INFORMATION CONTACT: H. 

Thomas Byron III, Esq., Chief Counsel, 

Rules Committee Staff, Administrative 

Office of the U.S. Courts, Thurgood 

Marshall Federal Judiciary Building, 

One Columbus Circle NE, Suite 7–300, 

Washington, DC 20544, Phone (202) 

502–1820, RulesCommittee_Secretary@

ao.uscourts.gov. 

(Authority: 28 U.S.C. 2073.) 

Dated: December 13, 2023. 

Shelly L. Cox, 

Management Analyst, Rules Committee Staff. 

[FR Doc. 2023–27766 Filed 12–15–23; 8:45 am] 

BILLING CODE 2210–55–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1308] 

Bulk Manufacturer of Controlled 

Substances Application: Kinetochem 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Kinetochem LLC has applied 

to be registered as a bulk manufacturer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before February 16, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before February 16, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 28, 2023, 

Kinetochem LLC, 96 Market Street, 

Suite 102, Georgetown, Texas 78626– 

3618, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana ........................ 7360 I 

Tetrahyrocannabinols ...... 7370 I 

The company plans to bulk 

manufacture the listed controlled 

substances as Active Pharmaceutical 

Ingredients to its customers as well as 

for research and clinical trials. In 

reference to drug codes 7360 


khammond on DSKJM1Z7X2PROD with NOTICES

I I 
Federal Register / Vol. 88, No. 241 / Monday, December 18, 2023 / Notices 87459 

(Marihuana), and 7370 

(Tetrahydrocannabinols) the company 

plans to bulk manufacture these drug 

codes as synthetic. No other activities 

for these drug codes are authorized for 

this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–27708 Filed 12–15–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1307] 

Importer of Controlled Substances 

Application: Siegfried USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Siegfried USA, LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 17, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 17, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on November 28, 2023, 

Siegfried USA, LLC, 33 Industrial Park 

Road, Pennsville, New Jersey 08070, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Phenylacetone ................. 8501 II 

Opium, raw ...................... 9600 II 

Poppy Straw Concentrate 9670 II 

The company plans to import the 

listed controlled substances to 

manufacture bulk Active 

Pharmaceuticals Ingredients for 

distribution to its customers. No other 

activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–27705 Filed 12–15–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1306] 

Bulk Manufacturer of Controlled 

Substances Application: AJNA 

BioSciences 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: AJNA BioSciences has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before February 16, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before February 16, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on September 20, 2023, 

AJNA BioSciences, 8022 Southpark 

Circle, Suite 500, Littleton, Colorado 

80120–5659, applied to be registered as 

a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Psilocybin ........................ 7437 I 

Psilocyn ........................... 7438 I 

The company plans to bulk 

manufacture by cultivating research 

Good Manufacturing Practices whole 

plant mushrooms containing Psilocybin 

(7437) and Psilocyn (7438) to support 

internal research, clinical trials, and 

analytical purposes as well as to 

distribute to their customers conducting 

schedule I clinical research. No other 

activities for these drug codes are 

authorized for this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–27707 Filed 12–15–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1309] 

Bulk Manufacturer of Controlled 

Substances Application: Groff Health, 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 


khammond on DSKJM1Z7X2PROD with NOTICES

I I 

I I